# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA666387 | F | Inhibitory concentration to prevent formation of Coxsackievirus B3 (CVB3) plaques | Coxsackievirus | 24 | organism-based format | Scientific Literature | ||
2. | ALA676536 | F | Inhibitory concentration to prevent formation of Enterovirus (EV 71) plaques | Enterovirus | 24 | organism-based format | Scientific Literature | ||
3. | ALA801765 | F | Cytotoxic effect of compound towards human Rhabdomyosarcoma cell line was evaluated | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
4. | ALA1653115 | F | Antiviral activity against 0.001 PFU/cell EV71 infected in human RD cells assessed as inhibition of viral plaque formation at 0.1 uM after 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
5. | ALA1653116 | F | Antiviral activity against 0.001 MOI EV71 infected in human RD cells assessed as inhibition of viral plaque formation 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
6. | ALA1653117 | F | Antiviral activity against 1 MOI EV71 infected in human RD cells assessed as inhibition of viral plaque formation 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
7. | ALA1653118 | A | Cytotoxicity against human RD cells after 16 hrs by MTS-based assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
8. | ALA1653119 | U | Selectivity index, ratio of CC50 for human RD cells to EC50 for 1 MOI EV71 infected in human RD cells | 1 | cell-based format | Scientific Literature | |||
9. | ALA1653120 | F | Antiviral activity against 0.001 PFU/cell EV71 TW/2231/98 infected in human RD cells assessed as inhibition of viral plaque formation after 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
10. | ALA1653121 | F | Antiviral activity against 0.001 PFU/cell EV71 TW/2231/98 infected in human RD cells assessed as inhibition of viral plaque formation after 5 passages by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
11. | ALA1653122 | F | Antiviral activity against 0.001 PFU/cell EV71 TW/2231/98 infected in human RD cells assessed as inhibition of viral plaque formation after 10 passages by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
12. | ALA1653123 | F | Antiviral activity against 0.001 PFU/cell EV71 TW/2231/98 infected in human RD cells assessed as inhibition of viral plaque formation after 14 passages by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
13. | ALA1653124 | F | Antiviral activity against EV71 infected in human RD cells assessed as inhibition of viral plaque formation 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
14. | ALA1653230 | F | Antiviral activity against EV71 harboring 2C protease T256A mutant gene infected in human RD cells assessed as inhibition of viral plaque formation 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
15. | ALA1653231 | F | Antiviral activity against EV71 harboring 3D protease R163K mutant gene infected in human RD cells assessed as inhibition of viral plaque formation 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
16. | ALA1653232 | F | Antiviral activity against EV71 harboring 3D protease R163K/S264L mutant gene infected in human RD cells assessed as inhibition of viral plaque formation 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
17. | ALA1653233 | F | Antiviral activity against EV71 harboring VP1 protease V192M mutant gene infected in human RD cells assessed as inhibition of viral plaque formation 16 hrs by plaque formation assay | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
18. | ALA1653234 | F | Antiviral activity against 1 MOI EV71 infected in human RD cells assessed as inhibition of viral progeny production at 1 uM treated 2 hrs postinfection measured after 16 hrs | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
19. | ALA1653235 | F | Antiviral activity against 1 MOI EV71 infected in human RD cells assessed as viral progeny production at 1 uM treated 4 hrs postadsorption measured after 16 hrs | Enterovirus A71 | 1 | organism-based format | Scientific Literature | ||
20. | ALA1653236 | F | Antiviral activity against 1 MOI EV71 infected in human RD cells assessed as inhibition of viral progeny production at 1 uM treated 4 hrs postadsorption measured after 16 hrs | Enterovirus A71 | 1 | organism-based format | Scientific Literature |